Location: Burlington, VT
CIK: 0001618205 · Show all filings
Period: Q1 2026 (← Previous) (Next →)
Filing Date: May 15, 2026
Total Value: $176M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| KLAC | KLA CORPORATION | 19,883 | $29.28M | 16.7% | $1472.41 | $798.69 | +83.1% | COM NEW | 482480100 |
| BMY | BRISTOL-MYERS SQUIBB CO | 306,268 | $18.58M | 10.6% | $60.65 * | $44.84 | +28.1% | COM | 110122108 |
| CMPX | COMPASS THERAPEUTICS INC | 1,465,867 | $7.754M | 4.4% | $5.29 * | $3.82 | +57.2% | COM | 20454B104 |
| LRCX | LAM RESEARCH CORPORATION | 36,000 | $7.692M | 4.4% | $213.66 * | $155.36 | +45.4% | COM NEW | 512807306 |
| STOK | STOKE THERAPEUTICS INC | 210,000 | $6.838M | 3.9% | $32.56 * | $12.13 | +162.5% | COM | 86150R107 |
| OVV | OVINTIV INC | 107,500 | $6.381M | 3.6% | $59.36 * | $35.12 | +24.4% | COM | 69047Q102 |
| NTLA | INTELLIA THERAPEUTICS INC | 445,400 | $5.71M | 3.3% | $12.82 * | $12.62 | -1.7% | COM | 45826J105 |
| GPCR | STRUCTURE THERAPEUTICS INC | 100,000 | $4.82M | 2.7% | $48.20 | $32.39 | — | SPONS ADR | 86366E106 |
| SLDB | SOLID BIOSCIENCES INC | 625,980 | $4.507M | 2.6% | $7.20 * | $5.15 | +17.4% | COM NEW | 83422E204 |
| PRTA | PROTHENA CORP PLC | 449,019 | $4.364M | 2.5% | $9.72 * | $20.62 | -55.8% | SHS | G72800108 |
| — | BIODESIX INC | 286,804 | $4.159M | 2.4% | $14.50 | $5.56 | — | COM | 09075X108 |
| ACAD | ACADIA PHARMACEUTICALS INC | 171,000 | $3.806M | 2.2% | $22.26 * | $27.98 | -9.9% | COM | 004225108 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 35,000 | $3.689M | 2.1% | $105.40 * | $39.90 | +108.7% | COM | 74366E102 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 27,190 | $3.582M | 2.0% | $131.74 | $73.35 | +83.1% | COM | 64125C109 |
| OLMA | OLEMA PHARMACEUTICALS INC | 219,000 | $3.265M | 1.9% | $14.91 * | $9.40 | +170.9% | COM | 68062P106 |
| RLMD | RELMADA THERAPEUTICS INC | 409,387 | $2.849M | 1.6% | $6.96 * | $4.01 | 0.0% | COM | 75955J402 |
| OCUL | OCULAR THERAPEUTIX INC | 320,000 | $2.71M | 1.5% | $8.47 * | $9.83 | 0.0% | COM | 67576A100 |
| UTHR | UNITED THERAPEUTICS CORP | 4,500 | $2.668M | 1.5% | $592.98 * | $222.21 | +116.2% | COM | 91307C102 |
| NKTR | NEKTAR THERAPEUTICS | 31,000 | $2.23M | 1.3% | $71.95 * | $53.00 | -8.8% | COM | 640268306 |
| CLDX | CELLDEX THERAPEUTICS INC | 70,095 | $2.223M | 1.3% | $31.72 * | $25.41 | 0.0% | COM NEW | 15117B202 |
| NVCR | NOVOCURE LTD | 202,330 | $2.205M | 1.3% | $10.90 * | $15.28 | -17.7% | ORD SHS | G6674U108 |
| EQT | EQT CORPORATION | 34,619 | $2.203M | 1.3% | $63.64 * | $33.40 | +65.5% | COM | 26884L109 |
| PHAT | PHATHOM PHARMACEUTICALS INC | 195,000 | $2.166M | 1.2% | $11.11 * | $11.94 | +14.7% | COM | 71722W107 |
| BCYC | BICYCLE THERAPEUTICS PLC | 463,599 | $2.151M | 1.2% | $4.64 | $7.30 | — | SPONSORED ADS | 088786108 |
| CMPS | COMPASS PATHWAYS LTD | 375,000 | $2.074M | 1.2% | $5.53 | $5.53 | — | SPONSORED ADS | 20451W101 |
| PACB | PACIFIC BIOSCIENCES OF CALIFORNIA INC | 1,500,000 | $1.98M | 1.1% | $1.32 * | $1.75 | +15.8% | COM | 69404D108 |
| CYTK | CYTOKINETICS INC | 30,000 | $1.977M | 1.1% | $65.91 * | $36.48 | +76.6% | COM | 23282W605 |
| CORT | CORCEPT THERAPEUTICS INC | 47,200 | $1.903M | 1.1% | $40.31 * | $14.57 | +166.3% | COM | 218352102 |
| VERA | VERA THERAPEUTICS INC | 44,000 | $1.77M | 1.0% | $40.23 * | $35.52 | +26.6% | CL A | 92337R101 |
| ALKS | ALKERMES PLC | 50,000 | $1.768M | 1.0% | $35.36 * | $21.00 | +54.0% | SHS | G01767105 |
| ENGN | ENGENE HOLDINGS INC | 250,000 | $1.702M | 1.0% | $6.81 * | $9.66 | 0.0% | COM | 29286M105 |
| QURE | UNIQURE NV | 100,697 | $1.646M | 0.9% | $16.35 * | $20.16 | +16.9% | SHS | N90064101 |
| ZBIO | ZENAS BIOPHARMA INC | 70,000 | $1.369M | 0.8% | $19.55 * | $21.89 | 0.0% | COM | 98937L105 |
| — | QUIDELORTHO CORP | 82,548 | $1.356M | 0.8% | $16.43 | $59.19 | — | COM | 74838J101 |
| FHTX | FOGHORN THERAPEUTICS INC | 281,730 | $1.347M | 0.8% | $4.78 * | $16.56 | -65.7% | COM | 344174107 |
| RARE | ULTRAGENYX PHARMACEUTICAL INC | 62,000 | $1.299M | 0.7% | $20.95 * | $37.12 | -37.1% | COM | 90400D108 |
| XENE | XENON PHARMACEUTICALS INC | 21,000 | $1.221M | 0.7% | $58.15 * | $34.29 | +22.4% | COM | 98420N105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 57,000 | $1.147M | 0.7% | $20.13 * | $15.61 | -0.8% | COM | 483497103 |
| IMNM | IMMUNOME INC | 50,000 | $1.093M | 0.6% | $21.87 * | $10.60 | +117.6% | COM | 45257U108 |
| FCX | FREEPORT-MCMORAN CL-B | 18,040 | $1.06M | 0.6% | $58.78 * | $37.70 | +62.1% | CL-B | 35671D857 |
| AXSM | AXSOME THERAPEUTICS INC | 6,000 | $1.014M | 0.6% | $169.02 * | $94.39 | +91.0% | COM | 05464T104 |
| BIIB | BIOGEN INC | 5,000 | $917K | 0.5% | $183.33 | $183.25 | 0.0% | COM | 09062X103 |
| LPCN | LIPOCINE INC | 111,786 | $893K | 0.5% | $7.99 * | $9.20 | 0.0% | COM NEW | 53630X203 |
| TVTX | TRAVERE THERAPEUTICS INC | 29,200 | $868K | 0.5% | $29.71 * | $13.34 | +132.6% | COM | 89422G107 |
| HROW | HARROW HEALTH INC | 24,000 | $846K | 0.5% | $35.26 * | $6.05 | +696.1% | COM | 415858109 |
| PHVS | PHARVARIS N V | 29,847 | $843K | 0.5% | $28.25 * | $23.14 | +15.6% | COM | N69605108 |
| VSTM | VERASTEM INC | 150,000 | $795K | 0.5% | $5.30 * | $8.91 | -27.3% | COM NEW | 92337C203 |
| APGE | APOGEE THERAPEUTICS INC | 9,000 | $758K | 0.4% | $84.17 * | $38.35 | +88.3% | COM | 03770N101 |
| HALO | HALOZYME THERAPEUTICS INC | 10,100 | $653K | 0.4% | $64.63 * | $51.35 | +43.4% | COM | 40637H109 |
| BBIO | BRIDGEBIO PHARMA INC | 8,688 | $645K | 0.4% | $74.26 | $41.64 | +78.9% | COM | 10806X102 |
| APLS | APELLIS PHARMACEUTICALS INC | 14,000 | $563K | 0.3% | $40.23 * | $39.43 | -42.5% | COM | 03753U106 |
| IDYA | IDEAYA BIOSCIENCES INC | 16,860 | $562K | 0.3% | $33.32 | $33.87 | 0.0% | COM | 45166A102 |
| RCUS | ARCUS BIOSCIENCES INC | 25,889 | $559K | 0.3% | $21.60 | $21.27 | 0.0% | COM | 03969F109 |
| RGNX | REGENXBIO INC | 66,270 | $555K | 0.3% | $8.38 * | $11.60 | 0.0% | COM | 75901B107 |
| — | KARYOPHARM THERAPEUTICS INC | 83,952 | $468K | 0.3% | $5.57 | $5.57 | — | COM | 48576U106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 127,025 | $455K | 0.3% | $3.58 | $3.61 | 0.0% | COM | 77313F106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 20,100 | $393K | 0.2% | $19.56 * | $30.84 | 0.0% | COM | 92790C104 |
| — | OUTSET MEDICAL INC | 98,882 | $380K | 0.2% | $3.84 | $9.28 | — | COM | 690145107 |
| LUNG | PULMONX CORP | 250,221 | $323K | 0.2% | $1.29 * | $1.88 | -7.8% | COM | 745848101 |
| CSTL | CASTLE BIOSCIENCES INC | 12,900 | $317K | 0.2% | $24.55 * | $23.48 | +56.6% | COM | 14843C105 |
| TRIN | TRINITY CAP INC | 20,000 | $294K | 0.2% | $14.71 * | $14.09 | +11.8% | COM | 896442308 |
| CADL | CANDEL THERAPEUTICS INC | 60,000 | $294K | 0.2% | $4.90 * | $5.91 | -2.9% | COM | 137404109 |
| VYGR | VOYAGER THERAPEUTICS INC | 74,918 | $289K | 0.2% | $3.86 | $4.67 | — | COM | 92915B106 |
| CGEM | CULLINAN THERAPEUTICS INC | 20,000 | $284K | 0.2% | $14.21 * | $40.60 | -70.5% | COM | 230031106 |
| KBDC | KAYNE ANDERSON BDC INC | 20,000 | $274K | 0.2% | $13.72 * | $14.18 | +0.6% | COM SHS | 48662X105 |
| GRCE | GRACE THERAPEUTICS INC | 50,000 | $232K | 0.1% | $4.63 * | $3.72 | 0.0% | COM | 00439U104 |
| ELUT | ELUTIA INC | 165,094 | $173K | 0.1% | $1.05 * | $5.84 | -84.0% | COM | 05479K106 |
| KYNB | KYNTRA BIO INC | 22,566 | $153K | 0.1% | $6.78 * | $8.36 | 0.0% | COM NEW | 31572Q881 |
| QNRX | QUOIN PHARMACEUTICALS LTD | 20,000 | $132K | 0.1% | $6.60 | $6.60 | — | SPONSORED ADS | 74907L409 |
| PHR | PHREESIA INC | 14,300 | $120K | 0.1% | $8.38 * | $21.44 | -33.5% | COM | 71944F106 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 17,503 | $40,957 | 0.0% | $2.34 * | $13.60 | -80.8% | COM | 98943L107 |
| DCGO | DOCGO INC | 39,573 | $24,895 | 0.0% | $0.63 * | $4.44 | -81.8% | COM | 256086109 |
| GOSS | GOSSAMER BIO INC | 18,176 | $5,971 | 0.0% | $0.33 * | $5.35 | -57.9% | COM | 38341P102 |